Articles from VisCardia
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
Publication marks a milestone for VisONE™ cardiac diaphragm support as enrollment continues in the RECOVER-HF pivotal IDE trial
By VisCardia · Via GlobeNewswire · October 22, 2026
VisCardia Implants First U.S. Patient in RECOVER-HF Pivotal Trial
Milestone in pivotal IDE evaluation of VisONE™ Synchronized Diaphragmatic Stimulation Therapy for symptomatic heart failure with reduced ejection fraction; FDA Breakthrough Device Designation
By VisCardia · Via GlobeNewswire · July 9, 2026